ZA772029B - Steroid anaesthetics - Google Patents

Steroid anaesthetics

Info

Publication number
ZA772029B
ZA772029B ZA00772029A ZA772029A ZA772029B ZA 772029 B ZA772029 B ZA 772029B ZA 00772029 A ZA00772029 A ZA 00772029A ZA 772029 A ZA772029 A ZA 772029A ZA 772029 B ZA772029 B ZA 772029B
Authority
ZA
South Africa
Prior art keywords
anaesthetics
steroid
steroid anaesthetics
Prior art date
Application number
ZA00772029A
Inventor
G Phillipps
G Ewan
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of ZA772029B publication Critical patent/ZA772029B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/008Ketals at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011Unsubstituted amino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00772029A 1976-04-05 1977-04-04 Steroid anaesthetics ZA772029B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13707/76A GB1581234A (en) 1976-04-05 1976-04-05 11a - amino - 3a - hydroxysteroids

Publications (1)

Publication Number Publication Date
ZA772029B true ZA772029B (en) 1978-11-29

Family

ID=10027931

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00772029A ZA772029B (en) 1976-04-05 1977-04-04 Steroid anaesthetics

Country Status (19)

Country Link
JP (1) JPS52142056A (en)
AU (1) AU517206B2 (en)
BE (1) BE853227A (en)
DE (1) DE2715078A1 (en)
DK (1) DK148677A (en)
ES (1) ES457507A1 (en)
FI (1) FI771046A (en)
FR (2) FR2347382A1 (en)
GB (1) GB1581234A (en)
IE (1) IE45276B1 (en)
IL (1) IL51816A (en)
IT (1) IT1073232B (en)
LU (1) LU77064A1 (en)
NL (1) NL7703667A (en)
NO (1) NO771197L (en)
NZ (1) NZ183775A (en)
PL (1) PL197186A1 (en)
SE (1) SE7703929L (en)
ZA (1) ZA772029B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044227B1 (en) * 1980-07-16 1983-08-24 Glaxo Group Limited 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
AU541732B2 (en) * 1980-07-16 1985-01-17 Glaxo Group Limited 11a-amino-androstanes
NZ199859A (en) * 1981-03-02 1984-10-19 Glaxo Group Ltd 11alpha-amino-3beta-hydroxy-androstanes
EP0066467B1 (en) * 1981-05-29 1984-08-08 Glaxo Group Limited 11-alpha-amino-androstanes
JPS57203100A (en) * 1981-05-29 1982-12-13 Glaxo Group Ltd 11 alpha-amino-androstanes
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
FR2910002B1 (en) * 2006-12-13 2009-01-30 Sanofi Aventis Sa NOVEL METHOD FOR THE DIASTEREOSELECTIVE OBTAINING OF A PRIMARY CHIRAL AMINE ON A STEROID
JP2010037243A (en) * 2008-08-04 2010-02-18 Mitsubishi Rayon Co Ltd Method for producing norbornene lactone monomer
CN108976272B (en) 2011-10-14 2021-05-25 萨奇治疗股份有限公司 3, 3-disubstituted 19-norpregnane compounds, compositions, and uses thereof
NZ627781A (en) 2012-01-23 2016-10-28 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
IL275725B (en) 2012-08-21 2022-08-01 Sage Therapeutics Inc Methods of treating epilepsy or status epilepticus
ES2807264T3 (en) 2013-04-17 2021-02-22 Sage Therapeutics Inc 19-nor neuroactive steroids for treatment methods
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
HUE041369T2 (en) 2013-04-17 2019-05-28 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
CA3199003A1 (en) * 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CA3235088A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (en) 2014-09-08 2017-06-16 Sage Therapeutics Inc Neuroactive steroids, compositions, and uses thereof
MX2017005002A (en) 2014-10-16 2018-01-23 Sage Therapeutics Inc Compositions and methods for treating cns disorders.
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
RS61530B1 (en) 2015-01-26 2021-04-29 Sage Therapeutics Inc Compositions and methods for treating cns disorders
DK3258939T3 (en) 2015-02-20 2022-12-12 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF
KR102408399B1 (en) 2016-03-08 2022-06-13 세이지 테라퓨틱스, 인크. Neuroactive steroids, compositions, and uses thereof
IL309259A (en) 2016-07-11 2024-02-01 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7065825B2 (en) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7, C12, and C16 replacement neurostimulatory steroids and how to use them
BR112020012761A2 (en) * 2017-12-22 2021-02-17 Sage Therapeutics, Inc. compositions and methods for the treatment of snc disorders
MX2021006618A (en) 2018-12-05 2021-09-23 Sage Therapeutics Inc Neuroactive steroids and their methods of use.
MA56046A (en) 2019-05-31 2022-04-06 Sage Therapeutics Inc NEUROACTIVE STEROIDS AND ASSOCIATED COMPOSITIONS
WO2020264512A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders
JP2022538300A (en) * 2019-06-27 2022-09-01 セージ セラピューティクス, インコーポレイテッド Compositions and methods for treating CNS disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2982775A (en) * 1957-05-06 1961-05-02 Schering Corp 11-oximino-, amino- and acylaminosteroids

Also Published As

Publication number Publication date
FR2485020A1 (en) 1981-12-24
IT1073232B (en) 1985-04-13
IL51816A (en) 1981-09-13
GB1581234A (en) 1980-12-10
DE2715078A1 (en) 1977-10-13
IE45276B1 (en) 1982-07-28
NL7703667A (en) 1977-10-07
SE7703929L (en) 1978-10-27
FR2347382A1 (en) 1977-11-04
ES457507A1 (en) 1978-03-16
PL197186A1 (en) 1979-06-18
AU517206B2 (en) 1981-07-16
BE853227A (en) 1977-10-04
NZ183775A (en) 1979-12-11
IE45276L (en) 1977-10-05
JPS52142056A (en) 1977-11-26
FR2347382B1 (en) 1982-01-08
IL51816A0 (en) 1977-06-30
NO771197L (en) 1977-10-06
LU77064A1 (en) 1979-01-18
FI771046A (en) 1977-10-06
AU2394277A (en) 1978-10-12
DK148677A (en) 1977-10-06

Similar Documents

Publication Publication Date Title
ZA772029B (en) Steroid anaesthetics
ZA7759B (en) Steroid anaesthetics
CS40277A2 (en) Zarovzdorna soucast pro nadoby obsahujici taveninu kovu
JPS52108409A (en) Oneebody structures
AU2142677A (en) Steroids
JPS5350152A (en) Pregnane derivatives
JPS52148062A (en) Steroids
ZA775915B (en) New corticoids
CS886177A2 (en) Nabijeci zarizeni pro automatickou strelnou zbran
IE46010L (en) Corticoids
JPS5655347A (en) Alkyll2*55diketogluconatee5*55dialkylacetal
JPS5331316A (en) Fireeproof structure
JPS5327228A (en) Panel
JPS52100714A (en) Panel for construction
ZA777725B (en) Indicia-display panel
GB1542246A (en) Bracket
JPS5297957A (en) Novel steroid compound
JPS5327223A (en) Panel for construction
JPS5283448A (en) Steroid
JPS5350558A (en) Panel
JPS539019A (en) Fireeproof honeyycomb panel
JPS5291518A (en) Panel
GB1554669A (en) Lock-latch set
JPS5353133A (en) Form set
JPS5313518A (en) Plateelike structure